Renal Cell Carcinoma

Chemokines as therapeutic targets in renal cell carcinoma
Targeting novel pathways associated with tumor angiogenesis, invasion and immunity, may lead to improvement in patient outcomes for renal cell carcinoma.
1500 E Duarte Road, MOB 1001
Duarte, CA 91010
USA
Targeted therapy for advanced renal cell carcinoma
BACKGROUND: Advanced renal cell carcinoma has been resistant to drug therapy of different types and new types of drug therapy are needed.


USA
Vaccination of metastatic renal cell carcinoma patients with autologous tumour-derived vitespen vacc
The aim of this study was to evaluate the clinical efficacy as determined by time to progression and response rate (RR) of autologous vitespen (formerly HSPPC-96; Oncophage, Antigenics Inc., New York, NY, USA) with and without interleukin-2 (IL-2; Proleukin: Chiron, Emoryville, CA, USA) in stage IV metastatic renal cell carcinoma (RCC) patients undergoing nephrectomy.
1515 Holcombe Boulevard, Unit 1374
Houston, TX 77030
USA
Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carc
PURPOSE: A phase I study of patients with metastatic malignant melanoma (MM) and renal cell carcinoma (RCC) evaluated the safety and maximum tolerated dose (MTD), pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of recombinant human interleukin-21 (rIL-21).
825 Eastlake Ave East, Mailstop G4-830
Seattle, WA 98109-1023
USA
Waiting Time From Initial Urological Consultation to Nephrectomy for Renal Cell Carcinoma-Does it Af
PURPOSE: We report survival and recurrence outcomes in all patients undergoing radical or partial nephrectomy for renal cell carcinoma, as related to surgical waiting time.

Nashville, TN
USA
Percutaneous Renal Cryoablation: Experience Treating 115 Tumors
PURPOSE: We determined technical feasibility, safety and short-term outcomes following percutaneous renal cryoablation.

Rochester, MN
USA
Safety and Activity of Sorafenib in Different Histotypes of Advanced Renal Cell Carcinoma
Background: The aim of our study was to evaluate the efficacy and safety in unresectable or advanced renal carcinoma treated with sorafenib, in a situation closely similar to the everyday medical practice.

Milan, Italy
Italy
Renal tumour surgery in elderly patients
OBJECTIVE To analyse morbidity, renal function and oncological outcome in patients aged >/=80 years who had surgery for renal tumours, as in the elderly such surgery is controversial in relation to life-expectancy and other causes of death.

Mainz, Germany
Germany
Enucleation of renal cell carcinoma with ablation of the tumour base
OBJECTIVE To retrospectively assess the effectiveness of cancer control with enucleation of renal cell carcinoma (RCC), which is surgically expedient, allows preservation of maximal renal parenchyma, and makes intraoperative renal ischaemia unnecessary, by two surgeons routinely enucleating renal tumours and ablating the tumour bed with argon beam and the Nd-YAG laser.

Philadelphia, PA
USA
Improving outcomes in patients with advanced renal cell carcinoma
The emergence of targeted therapies for advanced renal cell carcinoma has been a dramatic turning point in improving outcomes for the majority of patients with this disease.

Nashville, TN 27232
USA